What is SRC Medical?
Operating for over five decades, SRC Medical serves as a critical link in the supply chain for the medical, healthcare, and consumer goods industries. The company specializes in high-precision plastic injection molding, producing essential components such as custom dropper assemblies and specialized applicators. With an ISO 13485:2016 certification, SRC Medical distinguishes itself through a state-of-the-art manufacturing facility that meets the stringent regulatory requirements of the global pharmaceutical sector. Their market position is defined by a blend of legacy expertise and modern technical capability, allowing them to act as a primary partner for leading healthcare organizations requiring high-quality, compliant plastic solutions.
How much funding has SRC Medical raised?
SRC Medical has raised a total of $1M across 2 funding rounds:
Debt
$350K
Debt
$661K
Debt (2020): $350K with participation from PPP
Debt (2021): $661K led by PPP
Key Investors in SRC Medical
PPP
Public-Private Partnership
What's next for SRC Medical?
With the recent influx of capital, SRC Medical is well-positioned to accelerate its operational efficiency and expand its manufacturing footprint. The strategic focus will likely center on upgrading production technologies to meet the evolving demands of the pharmaceutical industry, particularly in the realm of complex, high-volume applicator manufacturing. As the company navigates its current growth phase, the emphasis remains on maintaining its reputation for quality assurance while scaling its output to support the increasing global demand for medical-grade plastic components. This financial stability provides the necessary runway to explore further automation and process optimization, ensuring the firm remains a competitive leader in the medical plastics landscape.
See full SRC Medical company page
